Vaccinex (United States)

Vaccinex | Pepinemab (anti-SEMA4D) & ActivMab Discovery Technology | Clinical Trials in Neurology and Oncology

Vaccinex has an novel antibody therapeutic pepinemab is an inhibitor of Semaphorin 4D (SEMA4D) that is in clinical trials for neurodegenerative diseases like Alzheimer's Disease and various cancers. Vaccinex also offers antibody discovery services with ActivMab - a novel technology to present transmembrane antigens like GPCRs on a poxvirus membrane for antibody discovery. We offer pre-clinical antibody services and poxvirus expertise to improve expression.